nemiDD

CTXR Chart Looks Nice + Upcoming Catalyst

做多
NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
Analyzing volume using 1hr candles. Take Aways:

1) Consolidating b/t 1.86 to 1.97 -> Needs to break over 2.02 for uptrend confirmation per fib levels
2) Price targets are 2.22 & 2.40 -> take 50% profit at 2.22 and let rest ride
2) Set SL @ 1.86 for a tight SL, @ 1.58 for loose, and @ 1.35 if you're portfolio can handle the choppiness we're in
3) Mino-lok goes for FDA approval late April. Nearest competition $CRMD failed approval roughly a month ago and dropped 60% on the news so please do not go full port on this

This is not financial advice and should only be used for entertainment purposes. Do your own due diligence.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。